ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Cadastre-se

Já é membro? Faça login

Moneta Markets

Abrir Conta

Moneta Markets
Dados
Notícias
Ferramentas
Mercados
Comunidade

Hot Features

Follow Feed

Conecte-se com traders e investidores em nossa comunidade Follow Feed.

Fluxo de Opções

Explore dados abrangentes de opções e utilize filtros avançados com Fluxo de Opções.

Monitor

Organize e monitore sua lista de ações e ativos com o Monitor.
Entrar Premium IconPremium Help Menu
Índice Bovespa
122.098,09
-0,50%
S&P 500
5.277,51
0,80%
US Dollar vs BRL
5,2463
0,01%
Bitcoin
67.615,62
0,20%
Brent Oil
81,295
0,00%
Registration Strip Icon for pro Negocie como um profissional: Aproveite discussões em tempo real e ideias que movimentam o mercado para superar a concorrência.
Cadastre-se
  1. Início
  2. Investir
  3. Ações
  4. EUA
  5. NASDAQ
  6. Savara Inc (SVRA)

  7. Savara Inc (SVRA) Notícias

SVRA

Savara (SVRA)

Savara Inc
De:
Ordenação:
 Apresentando as notícias mais relevantes sobre:NASDAQ:SVRA
DataHoraFonteTítuloCódigoCompanhia
29/05/202409:05Business WireSavara to Present at the Jefferies Global Healthcare ConferenceNASDAQ:SVRASavara Inc
22/05/202401:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:SVRASavara Inc
19/05/202413:15Business WireSavara Presented New Data on Autoimmune Pulmonary Alveolar Proteinosis (aPAP) at the American Thoracic Society (ATS) International Conference 2024NASDAQ:SVRASavara Inc
16/05/202417:05Business WireSavara Announces New Employment Inducement GrantNASDAQ:SVRASavara Inc
09/05/202417:46Edgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:SVRASavara Inc
09/05/202417:10Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:SVRASavara Inc
09/05/202417:05Business WireSavara Reports First Quarter 2024 Financial Results and Provides Business UpdateNASDAQ:SVRASavara Inc
07/05/202417:05Business WireSavara to Present at the Citizens JMP Life Sciences ConferenceNASDAQ:SVRASavara Inc
08/04/202409:05Business WireSavara to Present New Data on Autoimmune Pulmonary Alveolar Proteinosis (aPAP) at the American Thoracic Society (ATS) International Conference 2024NASDAQ:SVRASavara Inc
07/03/202418:26Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:SVRASavara Inc
07/03/202418:05Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:SVRASavara Inc
07/03/202418:05Business WireSavara Reports Fourth Quarter/Year-End 2023 Financial Results and Provides Business UpdateNASDAQ:SVRASavara Inc
06/03/202418:05Business WireSavara to Present at the Barclays 26th Annual Global Healthcare ConferenceNASDAQ:SVRASavara Inc
16/02/202410:31Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:SVRASavara Inc
14/02/202422:35Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:SVRASavara Inc
31/01/202416:08Edgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:SVRASavara Inc
31/01/202410:05Business WireSavara to Present at Two Upcoming Healthcare ConferencesNASDAQ:SVRASavara Inc
29/12/202318:35Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:SVRASavara Inc
28/12/202318:29Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:SVRASavara Inc
21/12/202310:05Business WireSavara Introduces aPAP ClearPath™, a GM-CSF Autoantibody Blood Test to Detect Autoimmune Pulmonary Alveolar Proteinosis (aPAP)NASDAQ:SVRASavara Inc
20/12/202310:05Business WireSavara Added to the NASDAQ Biotechnology IndexNASDAQ:SVRASavara Inc
21/11/202310:05Business WireSavara to Present at the Piper Sandler 35th Annual Healthcare ConferenceNASDAQ:SVRASavara Inc
09/11/202318:05Business WireSavara Reports Third Quarter Financial Results and Provides Business UpdateNASDAQ:SVRASavara Inc
08/11/202318:05Business WireSavara to Present at the Jefferies London Healthcare ConferenceNASDAQ:SVRASavara Inc
05/09/202317:05Business WireSavara to Present at the H.C. Wainwright 25th Annual Global Investment ConferenceNASDAQ:SVRASavara Inc
10/08/202317:05Business WireSavara Reports Second Quarter Financial Results and Provides Business UpdateNASDAQ:SVRASavara Inc
26/07/202317:57Edgar (US Regulatory)Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]NASDAQ:SVRASavara Inc
13/07/202318:17Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:SVRASavara Inc
13/07/202308:00Business WireSavara Announces Pricing of $80 Million Underwritten Offering of Common Stock and Pre-Funded WarrantsNASDAQ:SVRASavara Inc
26/06/202317:05Business WireSavara Added to Russell 3000® IndexNASDAQ:SVRASavara Inc
 Apresentando as notícias mais relevantes sobre:NASDAQ:SVRA

Seu Histórico Recente

BOV
IBOV
Índice Bovespa
BOV
PRIO3
PETRORIO ON
BOV
CIEL3
CIELO ON
BOV
PCAR3
PÃO DE AÇUCAR ON
BOV
SGPS3
SPRINGS ON
BOV
TPIS3
TRIUNFO PART ON
BOV
TECN3
TECHNOS ON
BOV
RCSL3
RECRUSUL ON
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Brasil
Empresa
Negócios
Popular
Obter o aplicativo
App Store
Google Play

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições

© 2024 ADVFN PLC - Todos os direitos reservados